Market Cap 1.95B
Revenue (ttm) 241.62M
Net Income (ttm) -25.03M
EPS (ttm) N/A
PE Ratio 73.20
Forward PE 48.06
Profit Margin -10.36%
Debt to Equity Ratio 0.28
Volume 2,670,400
Avg Vol 2,129,994
Day's Range N/A - N/A
Shares Out 33.56M
Stochastic %K 24%
Beta 2.12
Analysts Strong Sell
Price Target $102.00

Latest News on TMDX

5 Cheap Growth Stocks For 2025

Jan 5, 2025, 6:43 AM EST - 12 days ago

5 Cheap Growth Stocks For 2025

MELI NU NVDA TSM


TransMedics to Host Investor & Analyst Day on December 10, 2024

Nov 26, 2024, 4:05 PM EST - 7 weeks ago

TransMedics to Host Investor & Analyst Day on December 10, 2024


TransMedics: Long-Term Thesis Hasn't Changed At All

Nov 19, 2024, 11:27 AM EST - 2 months ago

TransMedics: Long-Term Thesis Hasn't Changed At All


TransMedics: Overreaction To Temporary Headwinds (Rating Upgrade)

Nov 12, 2024, 10:14 AM EST - 2 months ago

TransMedics: Overreaction To Temporary Headwinds (Rating Upgrade)


TransMedics: Maintaining A Neutral Stance After A Difficult Q3

Oct 30, 2024, 9:07 AM EDT - 2 months ago

TransMedics: Maintaining A Neutral Stance After A Difficult Q3